From 2007 to 2017, America experienced a 51% increase in drug overdose deaths. We have experienced losing 70,237 persons dying. With that, it has been estimated by the Substance Abuse and Mental Health Services Administration that 119 million people in the U.S. use some form of psychotropic drugs (44% of the population). Often, the abuse of substances is complicated by the co-occurrence of psychiatric disorders such as Complex PTSD, Anxiety, and Depressive Disorders with accompanying suicidality and interpersonal violence. Of those who receive treatment, some 75% will relapse.
This workshop will consider ways to achieve “lasting changes” in treatment through evidenced based, phase-oriented integrative core tasks of psychotherapy. A case Conceptualization Model of risk and protective factors that informs both assessment and treatment decision-making will be presented. The integration of spiritually oriented interventions such as 12-step programs, and active follow through family-based and community-based procedures will be highlighted, as well as ways in which patients can employ self-empowering resilience-engendering interventions. A comprehensive TO DO LIST will be provided, so attendees can take home interventions that they can use immediately, both professionally and personally.
Upon completion of this course, the participant will be able to:
Implement evidenced-based interventions with individuals with co-occurring substance-abuse and psychiatric disorders.
Use a Case Conceptualization Model that informs both assessment and treatment decision-making.
Increase the likelihood of achieving” lasting changes ” in substance-abusing individuals.
Learn how to spot HYPE in the field of psychotherapy.
This program has been approved for 4 hours Board approved CE for pharmacists. This program qualifies towards the opioid/addiction/drug of abuse requirement and LIVE CE. Program number 001-023-020-001.
Donald Meichenbaum, Ph.D.